Hyundai Bioscience said Sunday that it will co-develop a broad-spectrum antiviral drug with the US National Institutes of Health, a federal agency for conducting and supporting medical research and the world’s largest public funder of biomedical research. A non-clinical evaluation agreement was signed on Friday between Hyundai Bioscience USA, a US-based subsidiary of the Korean pharmaceutical company, and the N...
Related Keywords
, Antiviral Program For Pandemics , Us National Institutes Of Health , Korean Ministry Of Food , National Institute Of Allergy , Hyundai Bioscience , Hyundai Bioscience United States , National Institute , Infectious Diseases , Antiviral Program , South Korean Ministry , Drug Safety , The Korea Herald , Orean News , Oreaherald , Outh Korea News , Outh Korea News In English , Sia News , K Pop , Pop , 더코리아헤럴드 , 코리아 헤럴드 ,
comparemela.com © 2020. All Rights Reserved.